Partnerships and Strategy Updates:
Aledade changed its legal structure to that of a Public Benefit Corporation, meaning its governance is focused not solely on maximizing shareholder value, but also must consider furthering its designated 'public benefit purpose.' In Aledade's case, that purpose has been defined as 'To deliver better health, better care, and lower costs, creating a healthcare system that is good for patients, good for practices, and good for society.' I'm not sure what this changes as far as teh the actual governance or oversight changes, but there's another well-known PBC - Mark Cuban's Cost Plus Drugs. (Read more)
Optum partnered with 2 health systems - Owensboro Health and Northern Light Health in Maine. Both of these partnerships are similar in structure - the systems will offload their revenue cycle and IT functions (including ALL of the employees) to Optum. Look for more systems to engage in similar moves in
order to cut costs and headcount on the admin side.
HealthTrust and Ardent Health Services renewed their GPO agreement. (Read more)
CHS and Health Net renewed their Medi-Cal contract. (Read now)
Inside Intermountain's $600M campaign to reimagine pediatric care (Read more)
Transcarent partnered with the Cleveland Clinic that allows Transcarent members virtual access to the CC's 3,500 medical specialists. (Read more)
DocGo partnered with Redirect Health to offer non-emergent medical transport to Redirect Health's members across NJ and NY. (Read more)
Finance and M&A Updates:
UnitedHealth Group's (Lord UHG) full-year results: $324.2B in revenue, $20.1B in net income for the year. revenue by segment, before intercompany elims:
Premiums: $249.7B; Optum Health: $71.2B; OptumRx: $99.8B; OptumInsight: $14.6B; Intercompany elims: $108.3B
My full investor day breakdown here
Interesting little update on the Sanford-Fairview merger. Ownership of the University of Minnesota Medical Center (an academic medical center) is at the center of issues at hand during regulatory review, with local leadership stating they weren't made aware of merger plans prior to the announcement. (Read more)
Kaufman Hall released its hospital M&A 2022 in review, in which it anticipates seeing more 'cross-market' hospital mega-mergers. Interesting, sounds a lot like what I wrote about in June! And then I had a post titled '2022: Year of the Cross-Market Health System Mega-Merger' in November! Jokes aside, it's a nice summary of key data points and activity among hospitals in 2022.
Digital Health and Startup Updates:
Mark Cuban Cost Plus Drugs partnered with RxPreferredBenefits, giving employers and their members using its PBM access to MCCPD medications and the goal of extending the offering to local, independent pharmacies. (Read more)
ShiftKey raised $300M. (Read more)
Paytient, a BNPL healthcare fintech company focused on its creation of health payment accounts, raised $40.5M in a Series B led by Mercato Partners and $7.5M of which consisted of debt from Silicon Valley Bank. (Read more)
Suki provided some updates on its 2022 growth and operations, including a 7x increase in users. (Read more)
Policy and Payment Updates:
This was a fantastic, comprehensive write-up from Brendan Keeler & the Second Opinion team on key regulations to know for healthcare operators entering 2023. (Read more)
A couple of deadlines coming up from the Inflation Reduction Act:
9/1/23 - CMS drops the 10 drugs selected for negotiation
9/1/24 - Prices for these drugs are set, taking effect in 2026
The WSJ penned an thought-provoking op-ed on the British National Health Service on the current pitfalls facing its national healthcare system. (Read more)
VMG Health provided an overview of changes to the MPFS' final rule for diagnostic imaging & radiology. (Read more)
Costs, Data, and Other Updates:
The Veterans Affairs received another $1.8B to move forward with the Oracle-Cerner EHR rollout. (Read more)
FDA grants accelerated approval for Leqembi (Read more) Jared's perspective on balancing speed and safety in drug approvals (Read more)
I always enjoy looking at recent B2B marketing stuff in health tech, and the Differential's roundup was great here. (Read more)
Would love for subscribers to weigh in on this one: Ophelia, an opioid addiction treatment co, crafted a new marketing campaign called 'F*ck Rehab for Opioids' and it has drawn plenty of attention. (Read more)
(15px)
No comments